Latest KFF Health News Stories
Groupons For Medical Treatment? Welcome To Today’s U.S. Health Care
Groupon and other deal sites are the latest marketing tactic in medicine, offering bargain prices but potentially unnecessary, duplicative services.
Listen: India Gives Opioid Makers A Huge And Growing New Market
KHN’s Sarah Varney discussed opioid painkillers in India with NPR’s Rachel Martin on “Morning Edition” Thursday.
Analysis: How Your Beloved Hospital Helps To Drive Up Health Care Costs
It’s easy to criticize pharmaceutical and insurance companies. But we spend much more on hospitals.
Americans More Likely Than Swedes To Fill Prescriptions For Opioids After Surgery
New research published in JAMA Network Open quantified for the first time international differences in doctors’ prescribing habits and patients’ use of these highly addictive painkillers.
California Tries Again To Make Medication Abortions Available At Its Colleges
A proposed state law would require on-campus health centers to provide students with the medicines that allow them to end an unwanted pregnancy. Former Gov. Jerry Brown vetoed a similar bill last year, but Gov. Gavin Newsom has said he would sign it.
Firing Doctor, Christian Hospital Sets Off National Challenge To Aid-In-Dying Laws
In Colorado case, the right to aid a cancer patient’s death runs up against faith-based hospital policies. As more states have passed laws, about 1 in 6 acute care beds nationally is in a hospital that is Catholic-owned or -affiliated.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Comparando las farmacias de tu vecindario con las de Alemania
No son como CVS, Rite Aid o Walgreens, las que tienes a la vuelta de la esquina. Die Apotheke, como se llama aquí a una farmacia, vende casi exclusivamente medicamentos.
They Got Estimates Before Surgery — And A Bill After That Was 50% More
Patients are often told to be smart consumers and shop around for health care before they use it. What happens when people actually take that advice?
Shopping At The Apotheke: Compare German Pharmacies With Your Corner Drugstore
Germany’s pharmacies provide insights into the country’s low drug prices and strict regulations. But they’re still businesses.
In India’s Slums, ‘Painkillers Are Part Of The Daily Routine’
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.
Beset By Lawsuits And Criticism In U.S., Opioid Makers Eye New Market In India
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.
Pharma Cash Rolls Into Congress To Defend An Embattled Industry
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.
Judge Cites Opioid ‘Menace,’ Awards Oklahoma $572M In Landmark Case
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
Why Red Wyoming Seeks The Regulatory Approach To Air Ambulance Costs
Wyoming is taking on expensive air ambulance bills by trying to expand Medicaid to cover transport for all patients. This is a big change: a red state seeking to control what’s been a growing free-market bonanza.
Doctors Fight Legislation Prompted By Sex Abuse Scandals
In response to recent high-profile sex abuse cases, some California lawmakers want doctors to give patients more information about pelvic exams, and then get a signature proving they did. Doctors in the Golden State and beyond are pushing back.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Addiction Clinics Market Pricey, Unproven Treatments To Desperate Patients
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
Readers And Tweeters Take Dialysis Providers To Task: Nowhere But In The USA
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Dialysis Industry Spends Big To Protect Profits
Dialysis companies are fighting a bill in the California legislature that could disrupt their business model. Their weapons: campaign cash and a sophisticated public relations campaign.
